News from dipexium pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 20, 2015, 08:00 ET

Dipexium Pharmaceuticals Surpasses Treatment of 50% of Subjects in Pivotal Phase 3 Clinical Trial

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Aug 13, 2015, 07:00 ET

Dipexium Pharmaceuticals Reports Second Quarter 2015 Financial Results

 Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Aug 06, 2015, 08:00 ET

Dipexium Pharmaceuticals to Hold Second Quarter 2015 Financial Results Conference Call on Thursday, August 13, 2015, at 8:30 a.m. ET

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) will release its financial results for the quarter ended June 30, 2015, on Thursday, August 13, 2015...

Jul 28, 2015, 08:00 ET

Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Jun 30, 2015, 11:00 ET

Dipexium Announces Closing of Public Offering of Common Stock

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Jun 25, 2015, 09:12 ET

Dipexium Announces Pricing of Public Offering of Common Stock

 Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Jun 24, 2015, 16:04 ET

Dipexium Announces Proposed Public Offering of Common Stock

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Jun 02, 2015, 13:22 ET
Jun 02, 2015, 08:49 ET
Jun 02, 2015, 07:00 ET

Dipexium Receives European Medicines Agency Scientific Advice on Clinical and Regulatory Pathway for Locilex® Marketing Approval in European Union

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

May 22, 2015, 15:17 ET

Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético

- La presentación de póster científico destaca el diseño de los ensayos pivotales de fase 3 de Locilex® en la...

May 21, 2015, 12:25 ET

Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an

- Die wissenschaftliche Posterpräsentation stellt das Design der Phase-III-Zulassungsstudie von Locilex® bei leichten DFI vor...

May 21, 2015, 07:27 ET

Dipexium annonce une présentation lors du 7e International Symposium on the Diabetic Foot

- La présentation d'affiches scientifiques présente la conception des essais pivots de phase 3 du Locilex® pour les formes...

May 21, 2015, 07:00 ET

Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

May 14, 2015, 07:30 ET

Dipexium Pharmaceuticals Reports First Quarter 2015 Financial Results

 Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

May 07, 2015, 08:00 ET

Dipexium Pharmaceuticals to Hold First Quarter 2015 Financial Results Conference Call on Thursday, May 14, 2015, at 8:30 a.m. ET

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) will release its financial results for the quarter ended March 31, 2015, on Thursday, May 14, 2015 at...

Mar 24, 2015, 07:30 ET

Dipexium Pharmaceuticals Reports 2014 Financial Results

 Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Mar 18, 2015, 08:00 ET

Dipexium Pharmaceuticals to Hold Year End 2014 Financial Results Conference Call on Tuesday, March 24, 2015, 8:30 a.m. ET

 Dipexium Pharmaceuticals (NASDAQ: DPRX) will release its financial results for the year ended December 31, 2014, on Tuesday, March 24, 2015 at...

Mar 12, 2015, 11:00 ET

Dipexium Pharmaceuticals to Present at Jefferies 2015 Antibiotic Summit

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Feb 25, 2015, 09:00 ET

Dipexium Pharmaceuticals Passes 25% Enrollment in Locilex® Pivotal Phase 3 Clinical Trials

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), today announced that its two pivotal Phase 3 clinical trials, known as OneStep-1 and OneStep-2, have...